Vitaly Margulis, MD
Urology · Dallas, TXNPI 1134152937
Payments from drug & device makers
Across 603 payments — averaging $2934.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1.3M
- Johnson & Johnson$268K
- Progenics Pharmaceuticals, Inc.$111K
- Urogen Pharma, Inc.$26K
- Janssen Scientific Affairs, LLC$20K
- Blue Earth Diagnostics$7K
- plus $30K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 87 | $1,309,104 |
| Johnson & Johnson(2 entities) | 262 | $267,927 |
| Progenics Pharmaceuticals, Inc. | 87 | $110,878 |
| Urogen Pharma, Inc. | 35 | $25,575 |
| Janssen Scientific Affairs, LLC | 8 | $19,789 |
| Blue Earth Diagnostics | 8 | $6,602 |
| AstraZeneca | 12 | $4,678 |
| Eisai Inc. | 1 | $4,100 |
| Avyxa Pharma, LLC | 7 | $3,789 |
| Bayer | 5 | $3,135 |
| E.r. Squibb & Sons, L.L.C. | 3 | $2,497 |
| Genentech USA, Inc. | 2 | $2,197 |
| Telix Pharmaceuticals | 4 | $1,791 |
| Intuitive Surgical | 18 | $1,345 |
| Photocure Inc | 7 | $598 |
| Myriad Genetic Laboratories, Inc. | 4 | $597 |
| Dendreon Pharmaceuticals LLC | 3 | $520 |
| Endo Pharmaceuticals Inc. | 1 | $500 |
| Medtronic | 4 | $458 |
| Procept Biorobotics Corporation | 5 | $447 |
| Conmed Corporation | 4 | $439 |
| Boston Scientific | 5 | $367 |
| Stryker | 1 | $350 |
| Dr.reddy's Laboratories,inc. | 1 | $308 |
| Astellas Pharma US Inc | 2 | $244 |
| KARL Storz Endoscopy-america | 4 | $226 |
| Myovant Sciences Inc. | 6 | $180 |
| AVEO Pharmaceuticals, Inc. | 2 | $168 |
| Sumitomo Pharma America, Inc. | 4 | $167 |
| Immunitybio, Inc. | 1 | $150 |
| Foundation Medicine, Inc. | 2 | $139 |
| Laborie Medical Technologies Corp. | 3 | $122 |
| Profound Medical Corp. | 1 | $72 |
| Covidien LP | 1 | $56 |
| Innovation Technologies Inc | 2 | $49 |
| Pfizer | 1 | $15 |
How this compares
$1,769,580 in reported general payments places this provider in the 95th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Dallas
- Homa PorterDallas$1.8M
- Solomon WolduDallas$1.2M
- James CochranDallas$1.1M
- Yair LotanDallas$1.1M
- Allen MoreyDallas$1M
- Claus RoehrbornDallas$292K
- Brett JohnsonDallas$175K
- Pat FulghamDallas$174K
- Gregory ThoresonDallas$162K
- Zvi SchiffmanHouston$17.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.